ALR2-IN-9
ALR2-IN-9 is a potent ALR2 inhibitor (IC50 = 21.8 nM) with excellent antioxidant activity (EC50 for DPPH radical scavenging = 2.8 μM). ALR2-IN-9 interacts directly with Reactive Oxygen Species (ROS)/Reactive Nitrogen Species (RNS) and interrupts the free radical chain reactions, and as an endogenous enzymatic antioxidant regulator, which regulates enzyme functions of CAT and SOD. ALR2-IN-9 regulates PI3K/Akt/Nrf2 pathway to attenuate hyperglycemia-mediated mitochondrial superoxide overproduction in vitro, and ameliorates CuSO4- and H2O2-induced oxidative stress in vivo. ALR2-IN-9 prolongs lifespan of C. elegans via the regulation of stress response genes such as PMK-1. ALR2-IN-9 is a promising anti-aging drug candidate. ALR2-IN-9 can be used for diabetic complication research.
For research use only. We do not sell to patients.
- CAS No.: 2135481-84-2
- Formula: C25H28N4O6
- Molecular Weight:480.51
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
ALR2-IN-9 (compound 5N-D) (2.5-10 μM, 24h) ameliorates the impairments and ROS level in hyperglycemia Human Lymphatic Endothelial Cells (HLECs)[1].
ALR2-IN-9 (10 μM, 24 h) protects HLECs from high glucose-induced injury by activating the PI3K/Akt pathway, and reverses the hyperglycemia-reduced gene levels of Nrf2, HO-1, and NQO-1[1].
ALR2-IN-9 (10 μM, 1 h) demonstrates potent anti-oxidative efficacy by significantly attenuating the CuSO4-induced increase in ROS levels in zebrafish larvae[1].
ALR2-IN-9 (0.2 and 0.4 % wt%, 8 days) increases the mean lifespan, elevates the activity of SOD and CAT, and decreases the MDA level in C. elegans under oxidative stress[1].
ALR2-IN-9 (0.4 % wt%, 8 days) decreases ROS levels, reverses the H2O2-mediated suppression of AKT-1, SIR-2.1, DAF-16, and AGE-1, and further enhances the H2O2-induced upregulation of SKN-1 and PMK-1 in C. elegans[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HLECs
-
Concentration:2.5, 5.0, and 10 μM
-
Incubation Time:24 h
-
Result:Reversed this hyperglycemia-induced impairments, restoring cell viability to 85.2 % at the dose of 10 μM.
-
Cell Line:HLECs
-
Concentration:10 μM
-
Incubation Time:24 h
-
Result:Significantly increased the P-PI3K/PI3K and P-Akt/Akt ratios, compared to the high glucose group.
Failed to activate both PI3K and Akt in the presence of the specific PI3K inhibitor LY294002 (HY-10108).
Chemical Information
-
CAS No. 2135481-84-2
-
Molecular Weight 480.51
-
Formula C25H28N4O6
-
SMILES
CC(N[C@H](COCC1=CC=CC=C1)C(NCCCNC(/C(C#N)=C/C2=CC(O)=C(C=C2)O)=O)=O)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
ALR2-IN-9 Related Classifications
HY-175862 Related Classifications
Powered by Bioz